Physiologically based estimation of in vivo rates of bromodichloromethane metabolism

Toxicology

Volumn 124, Issue 2, 1997, Pages 141-152

  Lilly, Patrick D ^a,b,c   Andersen, Melvin E ^a,d   Ross, Tracey M ^a   Pegram, Rex A ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^d ICF Kaiser Engineers Inc   (United States)

Author keywords

Bromodichloromethane; Physiologically based modeling; Rates of metabolism; Water disinfection by products

Indexed keywords

BROMODICHLOROMETHANE; CYTOCHROME P450 ISOENZYME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; METABOLIC RATE; MODEL; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RAT; TOXICOKINETICS; XENOBIOTIC METABOLISM;

ANIMALS; BROMIDES; CARCINOGENS; CYTOCHROME P-450 CYP2E1; HYDROCARBONS, HALOGENATED; INHALATION EXPOSURE; KIDNEY; LIVER; MALE; RATS; RATS, INBRED F344; TRIHALOMETHANES;

ANIMALIA; RODENTIA;

EID: 0031587550     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00146-7     Document Type: Article

References (38)

1. Ade, P., Guastadisegni, C., Testai, E., Vittozzi, L., 1994. Multiple activation of chloroform in kidney microsomes from male and female DBA/2J mice. J. Biochem. Toxicol. 9, 289-295.
2. Ahmed, A.E., Kubic, V.L., Anders, M.W., 1977. Metabolism of haloforms to carbon monoxide I. In vitro studies. Drug Metab. Dispos. 5, 198-204.
3. Anders, M.W., Stevens, J.L., Sprague, R.W., Shaath, Z., Ahmed, A.E., 1978. Metabolism of haloforms to carbon monoxide II. In vivo studies. Drug Metab. Dispos. 6, 556-560.
4. Andersen, M.E., Clewell III, H.J., Gargas, M.L., Mac-Naughton, M.G., Reitz, R.H., Nolan, R.J., McKenna, M.J., 1991. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. Toxicol. Appl. Pharmacol. 108, 14-27.
5. Andersen, M.E., Clewell III, H.J., Frederick, C.B., 1995. Applying simulation modeling to problems in toxicology and risk assessment-a short perspective. Toxicol. Appl. Pharmacol. 133, 181-187.
6. Barton, H.A., Creech, J.R., Godin, C.S., Randall, G.M., Seckel, C.S., 1995. Chloroethylene mixtures: pharmacokinetic modeling in vitro metabolism of vinyl chloride, trichloroethylene, and trans-1,2-dichloroethylene. Toxicol. Appl. Pharmacol. 130, 237-247.
7. Cantor, K.P., Hoover, R., Mason, T.J., McCabe, J.L., 1978. Associations of cancer mortality with halomethanes in drinking water. J. Natl. Cancer Inst. 4, 979-985.
8. Corley, R.A., Mendrala, A.L., Smith, F.A., Staats, D.A., Gargas, M.L., Conolly, R.B., Andersen, M.E., Reitz, R.H., 1990. Development of a physiologically based pharmacokinetic model for chloroform. Toxicol Appl. Pharmacol. 103, 512-527.
9. Dunnick, J.K., Eustis, S.L., Lilja, H.S., 1987. Bromodichloromethane, a trihalomethane that produces neoplasms in rodents. Cancer Res. 47, 5189-5193.
10. Gargas, M.L., Andersen, M.E., 1982. Metabolism of inhaled brominated hydrocarbons: validation of gas uptake results by determination of a stable metabolite. Toxicol. Appl. Pharmacol. 66, 55-68.
11. Gargas, M.L., Andersen, M.E., 1989. Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation. Toxicol. Appl. Pharmacol. 99, 344-353.
12. Gargas, M.L., Clewell III, H.J., Andersen, M.E., 1986a. Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways. Toxicol. Appl. Pharmacol. 82, 211-223.
13. Gargas, M.L., Andersen, M.E., Clewell III, H.J., 1986b. A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicol. Appl. Pharmacol. 86, 341-352.
14. Gargas, M.L., Burgess, R.J., Voisard, D.E., Cason, G.H., Andersen, M.E., 1989. Partition coeffecients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98, 87-99.
15. Gargas, M.L., Clewell, H.J., Andersen, M.E., 1990. Gas uptake inhalation techniques and the rates of metabolism of chloromethanes, chloroethanes, and chloroethylenes in the rat. Inhal. Toxicol. 2, 295-319.
16. Guengerich, F.P., Kim, D.H., Iwasaki, M., 1991. Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168-179.
17. Krasner, S.W., McGuire, M.J., Jacangelo, J.G., Patania, N.L., Reagan, K.M., Aieta, E.M., 1989. The occurrence of disinfection by-products in US drinking water. J. Am. Water Works Assoc. 81, 41-53.
18. Krishnan, K., Andersen, M.E., 1994. Physiologically based pharmacokinetic modeling in toxicology. In: Hayes, A.W. (Eds.). Principles and Methods in Toxicology, 3rd ed. Raven Press, New York.
19. 125I]-2-iodo-3.7,8-trichlorodibenzodioxin in mice: analysis with a physiological modeling approach. Toxicol. Appl. Pharmacol. 103, 411-419.
20. Lilly, P.D., Simmons, J.E., Pegram, R.A., 1994. Dose-dependent vehicle differences in the acute toxicity of bromodichloromethane. Fundam. Appl. Toxicol. 23, 132-140.
21. Mathews, J.M., Troxler, P.S., Jeffcoat, A.R., 1990. Metabolism and distribution of bromodichloromethane in rats after single and multiple oral doses. J. Toxicol. Environ. Health 30, 15-22.
22. Miller, R.R., Letts, R.L., Potts, W.J., McKenna, M.J., 1980. Improved methodology for generating controlled test atmospheres. Am. Ind. Hyg. Assoc. J. 41, 844-846.
23. Morris, R.D., Audet, A.M., Angelillo, I.F., Chalmers, T.C., Mosteller, F., 1992. Chlorination, chlorination by-products, and cancer: a meta-analysis. Am. J. Public Health 82, 955-963.
24. Nakajima, T., Elovarra, E., Okino, T., Gelboin, H.V., Klockars, M., Riihikaki, V., Aoyana, T., Vainio, H., 1995. Different contributions of cytochrome P450 2E1 and P450 2B1/2 to chloroform hepatotoxicity in rat. Toxicol. Appl. Pharmacol. 133, 215-222.
25. National Institutes of Health, 1985. Guide for the care and use of laboratory animals. NIH Publication No. 86-23.
26. National Toxicology Program (NTP), 1987. Toxicology and Carcinogenesis Studies of Bromodichloromethane in F344/N Rats and B6C3F1 Mice. NIH Publication 88-2537, NTP TR 321.
27. Pegram, R.A., Andersen, M.E., Warren, S.H., Ross, T.M., Claxton, L.D., 1997. Glutathione S-transferase-mediated mutagenicity of trihalomethanes in Salmonella typhimurium TA 1535: contrasting results with bromodichloromethane and chloroform. Toxicol. Appl. Pharmacol. 144, 183-188.
28. Pohl, L.R., Bhooshan, B., Whittaker, N.F., Krishna, G., 1977. Phosgene: a metabolite of chloroform. Biochem. Biophys. Res. Commun. 5, 198-203.
29. Ramsey, J.C., Andersen, M.E., 1984. A physiologically based description of the inhalation pharmacokinetics of styrene monomer in rats and humans. Toxicol. Appl. Pharmacol. 73, 159-175.
30. Stevens, J.L., Anders, M.W., 1979. Metabolism of haloforms to carbon monoxide. III. Studies on the mechanism of the reaction. Biochem. Pharmacol. 28, 3189-3194.
31. Testai, E., Vitozzi, L., 1986. Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism. Chem.-Biol. Interact. 59, 157-171.
32. 3 carcinogenicity. Toxicol. Appl. Pharmacol. 114, 197-203.
33. Thier, R., Taylor, J.B., Pemble, S.E., Humphreys, W.G., Persmark, M., Ketterer, B., Guengerich, F.P., 1993. Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes. Proc. Natl. Acad. Sci. USA 90, 8576-8580.
34. Thornton-Manning, J.R., Gao, P., Lilly, P.D., Pegram, R.A., 1993. Acute bromodichloromethane toxicity in rats pretreated with cytochrome P450 inducers and inhibitors. Toxicologist 13, 361.
35. Thornton-Manning, J.R., Lilly, P.D., Andersen, M.E., 1994. Inhibition of CYP2E1 in rat liver microsomes by dichloroethylene isomers. Toxicologist 14, 54.
36. Tomasi, A., Albano, E., Biasi, F., Slater, T.F., Vannini, V., Dianzani, M.U., 1985. Activation of chloroform and related trihalomethanes to free radical intermediates in isolated hepatocytes and in the rat in vivo as detected by the ESR-spin trapping technique. Chem.-Biol. Interact. 55, 303-316.
37. US Environmental Protection Agency (US EPA), 1990. Final report for disinfection by-products in United States drinking waters. EPA 570/9-90/010a.
38. Wang, P.Y., Kaneko, T., Tsukada, H., Sato, A., 1994. Dose and route dependency of metabolism and toxicity of chloroform in ethanol-treated rats. Arch. Toxicol. 69, 18-23.